FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * ALBAN CARLOS   2. Issuer Name and Ticker or Trading Symbol AbbVie Inc. [ABBV] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Commercial Operations (Last) (First) (Middle) 1 N. WAUKEGAN ROAD 3. Date of Earliest Transaction (Month/Day/Year) 05/01/2013 (Street) NORTH CHICAGO, IL 60064 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common stock, $0.01 par value 05/01/2013   M   35,700 A $ 27.294 182,535 D   Common stock, $0.01 par value 05/01/2013   M   33,900 A $ 28.8628 216,435 D   Common stock, $0.01 par value 05/01/2013   M   17,700 A $ 28.1251 234,135 D   Common stock, $0.01 par value 05/01/2013   M   21,000 A $ 26.8472 255,135 D   Common stock, $0.01 par value 05/01/2013   M   34,600 A $ 28.3122 289,735 D   Common stock, $0.01 par value 05/01/2013   S   28,122 D $ 45.6837 261,613 D   Common stock, $0.01 par value 05/01/2013   S   27,320 D $ 45.6648 234,293 D   Common stock, $0.01 par value 05/01/2013   S   30,550 D $ 45.6768 203,743 D   Common stock, $0.01 par value 05/01/2013   S   27,664 D $ 45.6797 176,079 D   Common stock, $0.01 par value               40,442 (1) I Maria Cristina Alban 2007 Declaration of Trust

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Option (right to buy) (2)

$ 27.294

05/01/2013

M

35,700

02/16/2010

02/15/2017

Common stock

35,700

$ 0

0

D

Option (right to buy) (2)

$ 28.8628

05/01/2013

M

33,900

02/15/2011

02/14/2018

Common stock

33,900

$ 0

0

D

Option (right to buy) (2)

$ 28.1251

05/01/2013

M

17,700

02/20/2012

02/19/2019

Common stock

17,700

$ 0

0

D

Option (right to buy) (2)

$ 26.8472

05/01/2013

M

21,000

10/15/2012

10/14/2019

Common stock

21,000

$ 0

0

D

Option (right to buy) (2)

$ 28.3122

05/01/2013

M

34,600

02/19/2013

02/18/2020

Common stock

34,600

$ 0

0

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
ALBAN CARLOS 1 N. WAUKEGAN ROAD NORTH CHICAGO, IL 60064			EVP, Commercial Operations

Signatures

Steven L. Scrogham, attorney-in-fact for Carlos Alban		05/03/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Held in the Maria Christina Alban 2007 Declaration of Trust. The reporting person's spouse is trustee of the trust. The trust is revocable by his spouse. The reporting person disclaims beneficial ownership of these securities.
(2)	Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Remarks: These exercises were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.